Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CHUK | O15111 | 2/20 | 0.47 |
| ▸ | PLK4 | O00444 | 1/20 | 0.47 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.47 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.47 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.47 |
| ▸ | PRKACA | P17612 | 1/20 | 0.47 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.47 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.47 |
| ▸ | CLK2 | P49760 | 1/20 | 0.47 |
| ▸ | GSK3A | P49840 | 1/20 | 0.47 |
| ▸ | PRKX | P51817 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31660092 | 1.00 | PARP1 (0.50) | PARP1KDM4ETDP1CHUKPLK4 | |
| SCHEMBL29916420 | 0.87 | KDM4E (0.55) | PARP1KDM4ETDP1CLK4RAB9A | |
| SCHEMBL945856 | 0.87 | KDM4E (0.55) | PARP1KDM4ETDP1CLK4RAB9A | |
| SCHEMBL27967469 | 0.85 | KDM4E (0.52) | KDM4ETDP1CYP46A1CYP3A4CYP2C8 | |
| SCHEMBL4186883 | 0.85 | KDM4E (0.65) | PARP1KDM4ETDP1RAB9ACYP3A4 | |
| SCHEMBL30108233 | 0.84 | PARP1 (0.49) | PARP1KDM4ETDP1CHUKMKNK2 | |
| SCHEMBL6906432 | 0.84 | KDM4E (0.71) | KDM4ETDP1CYP46A1CYP3A4CYP2C8 | |
| SCHEMBL29453799 | 0.84 | KDM4E (0.71) | KDM4ETDP1CYP46A1CYP3A4CYP2C8 | |
| SCHEMBL1571384 | 0.83 | MKNK1 (0.55) | PARP1KDM4ETDP1PKN1PKN2 | |
| SCHEMBL29575496 | 0.83 | MKNK1 (0.55) | PARP1KDM4ETDP1PKN1PKN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | UNIV COLORADO REGENTS (US) | 2026-01-29 | — | — | US | claimed |
| WO-2021236696-A1 | SALIVA STABILIZATION SOLUTION FOR USE IN NUCLEIC ACID AMPLIFICATION REACTIONS AND METHODS OF USE FOR THE DETECTION OF PATHOGEN NUCLEIC ACIDS | THE REGENTS OF THE UNIVERSITY OF COLORADO A BODY CORPORATE (US) | 2021-11-25 | — | — | WO | claimed |
| CN-104086482-B | Chemical molecules inhibiting the splicing mechanism for the treatment of diseases caused by splicing abnormalities | 国家科研中心 | 2017-10-13 | — | — | CN | claimed |
| US-12590955-B2 | Methods and systems for processing particles | ZEON CORPORATION (JP) | 2026-03-31 | — | — | US | disclosed |
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | BATTELLE MEMORIAL INSTITUTE (US) | 2026-03-12 | — | — | US | disclosed |
| US-20250381163-A1 | Chelating Agents for Use in Cancer Therapy | PLECO THERAPEUTICS B V (NL) | 2025-12-18 | — | — | US | disclosed |
| US-12436081-B2 | Methods and devices for multi-step cell purification and concentration | ZEON CORPORTION (JP) | 2025-10-07 | — | — | US | disclosed |
| WO-2025089964-A1 | METHODS FOR TESTING ACTIVE COMPOUNDS IN MODELS WITH ELEVATED HEAVY METAL ACCUMULATION | PLECO THERAPEUTICS B.V. (NL) | 2025-05-01 | — | — | WO | disclosed |
| US-12258535-B2 | Emulsions having oil phase surfactants and water phase additive blends | PILOT CHEMICAL CORP. (US) | 2025-03-25 | — | — | US | disclosed |
| CN-119630394-A | Chelating agents for cancer treatment | 普雷高治疗有限公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20240368734-A1 | METHODS FOR EXTRACTING RARE EARTH ELEMENTS FROM RARE EARTH ELEMENT SOURCES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2024-11-07 | — | — | US | disclosed |
| EP-2971279-A2 | METHODS AND DEVICES FOR HIGH THROUGHPOUT PURIFICATION | The Trustees of Princeton University (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2971238-A1 | METAL COMPLEXING AGENTS AS CORROSION INHIBITORS | PRC-Desoto International, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2971287-A2 | ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES | GPB Scientific, LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-105247102-A | Metal complexes as corrosion inhibitors | PRC DESOTO INT INC | 2016-01-13 | — | — | CN | disclosed |
| CN-105247042-A | Method and apparatus for high throughput purification | UNIV PRINCETON | 2016-01-13 | — | — | CN | disclosed |
| WO-2014145075-A9 | METHODS AND DEVICES FOR HIGH THROUGHPOUT PURIFICATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2014-12-18 | — | — | WO | disclosed |
| WO-2014151491-A1 | METAL COMPLEXING AGENTS AS CORROSION INHIBITORS | PRC-DESOTO INTERNATIONAL, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014145075-A2 | METHODS AND DEVICES FOR HIGH THROUGHPOUT PURIFICATION | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014145152-A2 | ON-CHIP MICROFLUIDIC PROCESSING OF PARTICLES | GPB SCIENTIFIC, LLC (US) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071299-A1 | APPARATUS AND METHODS FOR RARE EARTH ELEMENT RECOVERY AND PURIFICATION | ERCC4, ERCC2, XPA | PARP1 3196/4885KDM4E 3353/4885TDP1 1749/4885 |
| US-20260028685-A1 | Saliva Stabilization Solution For Use In Nucleic Acid Amplification Reactions And Methods Of Use For The Detection Of Pathogen Nucleic Acids | RNASEH1, ACE2, DDX42 | PARP1 839/4885KDM4E 3634/4885TDP1 256/4885 |
| US-12590955-B2 | Methods and systems for processing particles | EZR, CD47, CD44 | PARP1 2784/4885KDM4E 4343/4885TDP1 4222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.